Australia markets closed

agilon health, inc. (AGL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
6.54+0.25 (+3.97%)
At close: 04:00PM EDT
6.73 +0.19 (+2.91%)
Pre-market: 04:09AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.59B
Enterprise value 2.22B
Trailing P/E N/A
Forward P/E 178.57
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.53
Price/book (mrq)3.75
Enterprise value/revenue 0.46
Enterprise value/EBITDA -104.52

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 3-63.95%
S&P500 52-week change 323.28%
52-week high 321.52
52-week low 34.41
50-day moving average 35.99
200-day moving average 39.02

Share statistics

Avg vol (3-month) 34.46M
Avg vol (10-day) 37.56M
Shares outstanding 5411.26M
Implied shares outstanding 6411.26M
Float 8305.39M
% held by insiders 11.79%
% held by institutions 1108.59%
Shares short (28 June 2024) 443.31M
Short ratio (28 June 2024) 48.17
Short % of float (28 June 2024) 441.88%
Short % of shares outstanding (28 June 2024) 410.53%
Shares short (prior month 31 May 2024) 443.89M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -5.85%
Operating margin (ttm)-0.30%

Management effectiveness

Return on assets (ttm)-6.62%
Return on equity (ttm)-22.82%

Income statement

Revenue (ttm)4.87B
Revenue per share (ttm)11.93
Quarterly revenue growth (yoy)52.20%
Gross profit (ttm)N/A
EBITDA -219.8M
Net income avi to common (ttm)-201.84M
Diluted EPS (ttm)-0.49
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)419.06M
Total cash per share (mrq)1.02
Total debt (mrq)47.95M
Total debt/equity (mrq)6.97%
Current ratio (mrq)1.33
Book value per share (mrq)1.68

Cash flow statement

Operating cash flow (ttm)-143.16M
Levered free cash flow (ttm)-110.33M